Published in Gut on December 01, 1999
Development of a triage protocol for critical care during an influenza pandemic. CMAJ (2006) 2.78
Transplantation in autoimmune liver diseases. World J Gastroenterol (2008) 0.94
Age and the allocation of organs for transplantation: a case study. Health Care Anal (2005) 0.82
Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer. PLoS One (2014) 0.82
Developments in liver transplantation. Gut (2004) 0.79
The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases. Langenbecks Arch Surg (2014) 0.77
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (1997) 10.05
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Anti-tuberculous therapy and acute liver failure. Lancet (1995) 6.27
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
North of England evidence based guidelines development project: methods of guideline development. BMJ (1996) 5.12
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Prognosis in primary biliary cirrhosis: model for decision making. Hepatology (1989) 3.83
Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer (1980) 3.82
Hepatitis C virus antibodies among risk groups in Spain. Lancet (1989) 3.66
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Meeting report: International Autoimmune Hepatitis Group. Hepatology (1993) 3.27
Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol (1993) 3.24
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology (1978) 3.21
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Compensated cirrhosis: natural history and prognostic factors. Hepatology (1987) 3.01
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96
Liver transplantation after paracetamol overdose. BMJ (1991) 2.81
Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol (1984) 2.79
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology (1995) 2.47
Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology (1990) 2.47
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health (1997) 2.33
Hepatocellular carcinoma: recent progress. Hepatology (1992) 2.33
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer (1996) 2.26
Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25
Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18
A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology (1995) 2.11
Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci (1986) 2.07
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ (1996) 2.04
Effect of coroners' rules on death certification for alcoholic liver disease. Br Med J (Clin Res Ed) (1985) 2.04
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet (1993) 2.00
Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology (1973) 1.99
Epidemiology of alcoholic liver disease. Semin Liver Dis (1988) 1.96
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Hepatic transplantation for primary and metastatic cancers of the liver. Surgery (1991) 1.93
Neuropathology of alcoholism. Alcohol Alcohol (1990) 1.91
Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology (1993) 1.90
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1996) 1.82
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med (1993) 1.79
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology (1996) 1.77
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology (1989) 1.75
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology (1985) 1.73
Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology (1991) 1.73
The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ (1992) 1.72
A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med (1992) 1.71
Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology (1990) 1.67
Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol (1993) 1.63
Liver transplantation for polycystic liver disease. Arch Surg (1990) 1.61
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Diagnosis and management of the Budd-Chiari syndrome. Am J Surg (1990) 1.58
Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med (1984) 1.58
Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol (1996) 1.57
Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.56
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology (1997) 1.55
Preoperative risk factor assessment in liver transplantation. Surgery (1992) 1.55
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Increasing age--an important adverse prognostic factor in hepatitis A virus infection. J R Coll Physicians Lond (1988) 1.48
Limits to liver transplantation in the UK. Gut (1998) 1.48
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol (1992) 1.46
Psychiatric and social outcome of liver transplantation. Br J Psychiatry (1995) 1.46
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43
Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol (1995) 1.41
Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology (1988) 1.40
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1994) 1.40
Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology (1983) 1.39
The incidence of portal vein thrombosis at liver transplantation. Hepatology (1992) 1.35
Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery (1994) 1.35
Primary hepatic malignancy: the role of liver transplantation. Br J Surg (1990) 1.34
Stratifying the causes of death in liver transplant recipients. An approach to improving survival. Arch Surg (1989) 1.33
Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med (1992) 1.32
Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology (1983) 1.32
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology (1997) 1.31
Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med (1984) 1.30
Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol (1988) 1.30
Transplantation in the nineties. Transplantation (1992) 1.29
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29
Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis (1986) 1.29
Chronic active hepatitis: the spectrum of disease. Lancet (1982) 1.28
Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol (1997) 1.27
Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology (1990) 1.24
Liver transplantation for Wilson's disease: indications and outcome. Hepatology (1994) 1.24
The quality of life following liver transplantation: a preliminary report. Gastroenterol Clin North Am (1988) 1.23
Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer (1988) 1.22
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet (1991) 1.20
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol (2004) 2.18
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry (2002) 1.81
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg (2001) 1.74
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
A double blind placebo controlled crossover study of prostacyclin in man. Life Sci (1979) 1.67
Motivational aspects of deliberate self-poisoning in adolescents. Br J Psychiatry (1982) 1.62
Adolescents who take overdoses: their characteristics, problems and contacts with helping agencies. Br J Psychiatry (1982) 1.59
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. Br J Clin Pharmacol (1982) 1.48
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. Am J Hematol (1991) 1.43
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J (2008) 1.43
Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man. Eur J Cardiol (1980) 1.36
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35
Stenoses of vascular anastomoses after hepatic transplantation: treatment with balloon angioplasty. AJR Am J Roentgenol (1991) 1.34
Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts. J Eukaryot Microbiol (2000) 1.32
Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30
Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation (1994) 1.11
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut (2007) 1.11
Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases. Fam Pract (2001) 1.11
Aspirin: A paradoxical effect on bleeding-time. Lancet (1978) 1.08
Hyperacute rejection in liver transplantation: a case report. Transplant Proc (1989) 1.07
Late onset hepatic failure: clinical, serological and histological features. Hepatology (1986) 1.06
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med (1984) 1.05
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Am J Trop Med Hyg (2004) 1.05
A modified larval migration assay for detection of resistance to macrocyclic lactones in Haemonchus contortus, and drug screening with Trichostrongylidae parasites. Vet Parasitol (2006) 1.04
Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Trop Med Int Health (2012) 0.99
Epidemiology, bacteriology and control of an outbreak of Nocardia asteroides infection on a liver unit. J Hosp Infect (1991) 0.99
Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. Br Med J (1980) 0.99
Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol (1992) 0.98
Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis (1999) 0.97
Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology (1992) 0.97
Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience (2005) 0.95
Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol (1999) 0.95
Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patients. Transplant Proc (1989) 0.95
Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology (1993) 0.93
Genetic variation in DNMT3B and increased global DNA methylation is associated with suicide attempts in psychiatric patients. Genes Brain Behav (2012) 0.93
A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man. Br J Clin Pharmacol (1984) 0.91
Liver transplantation in adults coinfected with HIV. Transplantation (2001) 0.91
Exploring the anthelmintic properties of Australian native shrubs with respect to their potential role in livestock grazing systems. Parasitology (2009) 0.91
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med (1991) 0.90
Tuberculosis in prisons: anatomy of global neglect. Eur Respir J (2011) 0.89
Clinical pharmacology in the pharmaceutical industry. Br J Clin Pharmacol (1991) 0.89
Assessment of portal venous system patency in the liver transplant candidate: a prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery. Clin Radiol (2002) 0.89
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut (2006) 0.89
The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1982) 0.87
Hyperalphalipoproteinemia and prostaglandin I2 stability. Thromb Res (1997) 0.87
Epoprostenol (prostacyclin) decreases platelet deposition on vascular prosthetic grafts. Lancet (1983) 0.87
Toxicity of Bacillus thuringiensis to parasitic and free-living life-stages of nematode parasites of livestock. Int J Parasitol (2005) 0.86
Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet (1988) 0.86
The distribution of free and non-ionic vesicular sodium stibogluconate in the dog. J Drug Target (1993) 0.86
Assessment of potential donors for living related liver transplantation. Br J Surg (1999) 0.86
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo. Postgrad Med J (1987) 0.86
Comparison of the Glasgow alcoholic hepatitis score and the ABIC score for the assessment of alcoholic hepatitis. Am J Gastroenterol (2010) 0.85
Organ transplantation in hereditary apolipoprotein AI amyloidosis. Am J Transplant (2006) 0.85
Effect of a standard breakfast on digoxin absorption in normal subjects. Clin Pharmacol Ther (1978) 0.85
Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. Aliment Pharmacol Ther (2013) 0.85
Inhibition of lung immunity after intratracheal instillation of benzo(a)pyrene. Am J Respir Crit Care Med (1994) 0.84
Classification of adolescents who take overdoses. Br J Psychiatry (1982) 0.84
Effects of single oral dose administration of a hydantoin prostaglandin analogue BW 245C in man. Life Sci (1984) 0.84
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand. Br J Cancer (1990) 0.84
Treatment of hypercholesterolaemia in children. Lancet (1992) 0.83
A serological investigation of human herpesvirus 6 infections in liver transplant recipients and the detection of cross-reacting antibodies to cytomegalovirus. J Med Virol (1991) 0.83
Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med (1991) 0.83
Linguistic processing during repetitive transcranial magnetic stimulation. Neurology (1998) 0.82
Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Br J Dermatol (2006) 0.82
Human liver regeneration is characterized by the coordinated expression of distinct microRNA governing cell cycle fate. Am J Transplant (2013) 0.82
99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro. Br J Clin Pharmacol (1990) 0.82
Prostacyclin in Falciparum malaria. Lancet (1982) 0.81
Effect of a hydantoin prostaglandin analogue, BW245C, during oral dosing in man. Prostaglandins (1985) 0.81
Drug chirality: a consideration of the significance of the stereochemistry of antimicrobial agents. J Antimicrob Chemother (1996) 0.81
Share 35: a liver in time saves lives? Am J Transplant (2015) 0.81
Prostacyclin increases filterability of normal and rigidified human red blood cells in vitro. Agents Actions (1984) 0.81
Effect of prostacyclin (PGI2) on water and solute transport in the human jejunum. Gut (1986) 0.80
Effect of epoprostenol on platelet deposition on synthetic artery grafts. Lancet (1984) 0.80
Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man. Eur J Clin Pharmacol (1978) 0.80
Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection. Thromb Res (1996) 0.80
Detection of UV-induced thymine dimers in individual Cryptosporidium parvum and Cryptosporidium hominis oocysts by immunofluorescence microscopy. Appl Environ Microbiol (2006) 0.80
Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol (1998) 0.80
Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis. Thromb Res (1996) 0.79
Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states. Liver Transpl (2001) 0.79
Prolonged paradoxical effect of aspirin on platelet behaviour and bleeding time in man. Thromb Res (1979) 0.79
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. Lancet (1990) 0.79
Sleep disturbance and appetite loss after lovastatin. Lancet (1994) 0.79
The economy class syndrome--a survey of 19 cases. Vasa (1999) 0.79
Importance of concomitant viral infection during late acute liver allograft rejection. Transplantation (1995) 0.79
Beneficial effect of long-term PGE1-treatment in left ventricular heart failure. Prostaglandins Leukot Essent Fatty Acids (1989) 0.79
Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology (1996) 0.79
Management of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantation. Transplant Proc (2001) 0.79
Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation (2001) 0.79
Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. Am J Transplant (2012) 0.79
Cigarette smoking does not attenuate the cardiovascular effects of epoprostenol (prostacyclin) in humans. Br J Clin Pharmacol (1982) 0.78